China NMPA E2B(R3) export
Summary
Oracle Argus is enhanced to schedule, generate, transmit, track, and submit E2B(R3) reports according to the Implementation guide published by NMPA.
Description
The National Medical Products Administration (NMPA), formerly known as the China Food and Drug Administration or CFDA, published the Regional implementation guide for E2B(R3) reporting in November 2019. The implementation guide defines 19 China specific E2B(R3) regional data elements and business rules regarding the submissions of E2B(R3) to the Center for Drug Reevaluation, NMPA, and to the Center for Drug Evaluation, NMPA.
Argus is now enhanced to schedule, generate, transmit, track, and submit E2B(R3) reports following the Implementation guide published by NMPA.
- Case Form
- Console
- Interchange mapping
- Reports generation, track, transmission and submission
- Validation and attachments
Case Form
- Case Form > Product > Product Information > Related Device Comments
- Case Form > General > Reporter Information > Institution
- Case Form > Patient and Parent > Pregnancy Information > Delivery Notes
- Case Form > Products > Product Information > Product Name
- Case Form > Products > Product Information > Generic Name
Console
- Console > Code Lists > Argus > Case Classification
- Console > Code Lists > Argus > Ethnicity
- Console > Code Lists > Flexible re-categorization > CASE_CLASSIFICATION
- Console > Code Lists > Flexible re-categorization > ETHNIC_GROUP
- Console > Code Lists > Flexible re-categorization > ETHNICITY
- Console > Code Lists > Flexible re-categorization > MANUFACTURER
- Console > Code Lists > Flexible re-categorization > CAUSALITY_CATEGORY
- Console > Code Lists > Flexible re-categorization > ROUTE
- Console > Code Lists > Flexible re-categorization > FORMULATION
Interchange mapping
The ICH-ICSR V3.0 MESSAGE TEMPLATE – NMPA message profile template, with default mappings for export and conformance rules according to the NMPA guidelines, is now added for E2B(R3) reporting to NMPA.
The ICH-ICSR V3.0 ACKNOWLEDGEMENT TEMPLATE – ICH existing acknowledgment profile template is used to receive acknowledgment from NMPA.
The 19 China-specific E2B(R3) regional data elements are listed in the following table:
Element number | Element description | Argus UI source |
---|---|---|
C.1.CN.1 | Source of Reports | Case Form > General > Case Classification |
C.1.CN.2 | Report Categories | Derived from:
|
C.1.CN.3 | Holder Identification | Code Lists > Reporting Destination > Local Company Contact > Lab Code |
C.2.r.CN.1 | Reporter's Email | Case Form > General > Reporter Information > Email |
D.CN.1 | Minority | Case Form > Patient > Patient Information > Ethnic Group |
D.CN.2 | Race | Case Form > Patient > Patient Information > Race Information > Race |
D.CN.3 | Medical Institution Name
Data in Chinese |
Case Form > General > Reporter Information > Institution |
D.CN.4 | Nationality | Case Form > Patient > Patient Information > Country |
D.CN.5 | Patient Telephone | Case Form > Patient > Patient Information > Phone |
D.CN.6 | Pregnancy Description
Data in Chinese |
Case Form > Patient or Parent > Pregnancy Information > Delivery Notes |
G.k.CN.1 | Generic Name of Drug
Data in Chinese |
Case Form > Products > Product Information > Generic Name |
G.k.CN.2 | Related Device
Data in Chinese |
Case Form > Product > Product Details > Related Device Comments |
G.k.CN.3 | Is the product owned by the holder | Derived from:
|
G.k.CN.4 | Approval/Acceptance Number | Derived from:
|
G.k.4.r.CN.1 | Expiration Date/Date of Expiry | Case Form > Products > Dosage Regimens > Expiration Date |
G.k.9.i.CN.1 | Is the reaction unexpected? | Derived from:
|
G.k.9.i.CN.2 | Did the reaction disappear or was the reaction relieved after the drug was withdrawn or the dose was reduced? | Derived from:
|
G.k.9.i.2.r.CN.1 | Original Reporter/ Source of Assessment | Case Form > Events > Event Assessment > Causality as Reported Source, Causality as Determined Source |
G.k.9.i.2.r.CN.2 | Result of Assessment | Case Form > Events > Event Assessment > Causality as Reported Result, Causality as Determined Result |
For details of NMPA E2B(R3) mappings, validations and appendix, refer to the ArgusInterchange8231_E2B (R3) Export Mappings.xlsx eTRM document.
Reports generation, tracking, transmission and submission
The NMPA E2B(R3) report generation, track, transmission and submission is similar to the E2B(R3) framework in Argus. The report is generated in the HL7 format, with the appropriate comments embedded in XML, for an easy identification of the data elements.
- XML view
- HL7 view
- Decoded view
You can send and track reports under Worklist > Bulk ICSR Transmit and Utilities > ICSR > ICSR Transmit Status. The AS2 protocol gateway support is provided to send and receive files.
Validation and attachments
The NMPA E2B(R3) profile is provided with validation rules as a part of factory data. The rules are based on the NMPA regulations. During the E2B(R3) report generation, the ICSR Validation verifies the case data against the rules and the ICSR validation report displays the list of failures.
The attachment types supported for NMPA E2B(R3) are provided as part of factory data in the newly introduced common profile switch in Reporting > E2B > File attachments allowed for the NMPA E2B(R3) Profile.
For more information on configuration and reporting, refer to the China NMPA E2B(R3) Best Practices document.
Parent topic: Enhancements to Oracle Argus Safety